Graham Capital Management, L.P. Seagen Inc. Transaction History

Graham Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $418,525 - $557,260	3,094 New	3,094 $423,000
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $253,932 - $335,115	-2,123 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $302,676 - $405,195	2,123 New	2,123 $328,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.